Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.36 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | STS | P08842 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6691816 | 0.94 | ALK (0.37) | POLBMTNR1AMTNR1B | |
| SCHEMBL6540929 | 0.90 | TSHR (0.47) | TSHRCA1CA2NLRP3POLB | |
| SCHEMBL6540091 | 0.88 | TSHR (0.47) | TSHRCA1CA2NLRP3POLB | |
| SCHEMBL6805809 | 0.87 | MEN1 (0.44) | POLBMTNR1AMTNR1B | |
| SCHEMBL6682542 | 0.87 | MTNR1A (0.39) | TSHRCA1CA2NLRP3MTNR1A | |
| SCHEMBL6678034 | 0.86 | CA1 (0.42) | TSHRCA1CA2NLRP3MTNR1A | |
| SCHEMBL6541242 | 0.85 | CA1 (0.40) | TSHRCA1CA2NLRP3MTNR1A | |
| SCHEMBL6540531 | 0.84 | CA1 (0.41) | TSHRCA1CA2CA9STS | |
| SCHEMBL6541199 | 0.83 | CA1 (0.40) | CA1CA2NLRP3CA7CA9 | |
| SCHEMBL6679678 | 0.83 | POLB (0.43) | CA1CA2POLBMTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106653-A1 | Aminoalcohol derivatives | FANCD2, FANCI, HRH2 | TSHR 4442/4885CA1 2450/4885CA2 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.